[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,515,908
  • Shares Outstanding, K 319,023
  • Annual Sales, $ 3,019 M
  • Annual Income, $ 72,060 K
  • EBIT $ 434 M
  • EBITDA $ 680 M
  • 60-Month Beta 1.30
  • Price/Sales 1.82
  • Price/Cash Flow 11.03
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 71.97% (+5.12%)
  • Historical Volatility 35.52%
  • IV Percentile 33%
  • IV Rank 40.07%
  • IV High 175.93% on 03/30/26
  • IV Low 2.47% on 09/09/25
  • Expected Move (DTE 17) 1.18 (6.83%)
  • Put/Call Vol Ratio 0.17
  • Today's Volume 56
  • Volume Avg (30-Day) 165
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 2,376
  • Open Int (30-Day) 2,691
  • Expected Range 16.13 to 18.49

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.24
  • Number of Estimates 1
  • High Estimate $0.24
  • Low Estimate $0.24
  • Prior Year $0.23
  • Growth Rate Est. (year over year) +4.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.49 +38.59%
on 06/03/26
17.86 -3.08%
on 06/26/26
+4.14 (+31.44%)
since 05/29/26
3-Month
11.76 +47.19%
on 05/19/26
17.86 -3.08%
on 06/26/26
+5.36 (+44.85%)
since 03/30/26
52-Week
7.66 +125.83%
on 08/01/25
17.86 -3.08%
on 06/26/26
+9.22 (+113.97%)
since 06/30/25

Most Recent Stories

More News
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations

Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa...

AMRX : 17.31 (+0.12%)
1 Mooning Stock Worth Your Attention and 2 We Question

1 Mooning Stock Worth Your Attention and 2 We Question

UAL : 135.99 (+0.59%)
AMRX : 17.31 (+0.12%)
ASTE : 61.19 (+0.56%)
1 Small-Cap Stock for Long-Term Investors and 2 We Find Risky

1 Small-Cap Stock for Long-Term Investors and 2 We Find Risky

NSIT : 121.80 (+1.15%)
TTD : 18.08 (-3.06%)
AMRX : 17.31 (+0.12%)
Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal Pharmaceuticals

Amneal's Commitment Helps Support a Reliable Supply of Essential Medicines for Uninsured and Underserved Patients Nationwide

AMRX : 17.31 (+0.12%)
3 Russell 2000 Stocks with Open Questions

3 Russell 2000 Stocks with Open Questions

RXO : 27.59 (+1.40%)
TDUP : 6.85 (-2.14%)
AMRX : 17.31 (+0.12%)
Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

Phase 4 ELEVATE-PD interim data from the entire study population (n=214) continue to show clinically meaningful, consistent benefits of CREXONT across all prior treatment groups Substantial increases...

AMRX : 17.31 (+0.12%)
Why Amneal (AMRX) Stock Is Trading Up Today

Why Amneal (AMRX) Stock Is Trading Up Today

AMRX : 17.31 (+0.12%)
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution

Ready-to-use romidepsin formulation; offers a more convenient alternative to lyophilized powder requiring reconstitution Competitive Generic Therapy approval provides 180 days of market exclusivity...

AMRX : 17.31 (+0.12%)
3 Profitable Stocks with Open Questions

3 Profitable Stocks with Open Questions

USNA : 21.35 (+1.62%)
WST : 359.00 (+1.22%)
AMRX : 17.31 (+0.12%)
Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

BRIDGEWATER, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), today announced that Chirag Patel, Co-Chief Executive and President,...

AMRX : 17.31 (+0.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 80%. The market is in extreme overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories...

See More

Key Turning Points

3rd Resistance Point 17.80
2nd Resistance Point 17.64
1st Resistance Point 17.48
Last Price 17.31
1st Support Level 17.16
2nd Support Level 17.00
3rd Support Level 16.84

See More

52-Week High 17.86
Last Price 17.31
Fibonacci 61.8% 13.97
Fibonacci 50% 12.76
Fibonacci 38.2% 11.56
52-Week Low 7.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.